These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
321 related items for PubMed ID: 9399220
1. Effect of chronic oral domperidone therapy on gastrointestinal symptoms and gastric emptying in patients with Parkinson's disease. Soykan I, Sarosiek I, Shifflett J, Wooten GF, McCallum RW. Mov Disord; 1997 Nov; 12(6):952-7. PubMed ID: 9399220 [Abstract] [Full Text] [Related]
5. [A long-term clinical effect of selegiline hydrochloride on Parkinson's disease]. Mizuno Y, Kondo T, Takubo H, Yokochi F. No To Shinkei; 1996 May; 48(5):467-72. PubMed ID: 8672306 [Abstract] [Full Text] [Related]
6. Ropinirole versus bromocriptine in the treatment of early Parkinson's disease: a 6-month interim report of a 3-year study. 053 Study Group. Korczyn AD, Brooks DJ, Brunt ER, Poewe WH, Rascol O, Stocchi F. Mov Disord; 1998 Jan; 13(1):46-51. PubMed ID: 9452325 [Abstract] [Full Text] [Related]
9. Effect of erythromycin on gastric and gallbladder emptying and gastrointestinal symptoms in scleroderma patients is maintained medium term. Fiorucci S, Distrutti E, Gerli R, Morelli A. Am J Gastroenterol; 1994 Apr; 89(4):550-5. PubMed ID: 8147358 [Abstract] [Full Text] [Related]
10. Levodopa + carbidopa + entacapone. Entacapone: a second look: new preparations. Parkinson's disease: a modest effect. Prescrire Int; 2005 Apr; 14(76):51-4. PubMed ID: 15875340 [Abstract] [Full Text] [Related]
15. High-dose treatment with pergolide in Parkinson's disease patients with motor fluctuations and dyskinesias. Storch A, Trenkwalder C, Oehlwein C, Winkelmann J, Polzer U, Hundemer HP, Schwarz J. Parkinsonism Relat Disord; 2005 Sep; 11(6):393-8. PubMed ID: 15993640 [Abstract] [Full Text] [Related]
16. [Rasagiline in daily clinical use. Results of a treatment study of Parkinson patients with a combination treatment]. Jost WH, Klasser M, Reichmann H. Fortschr Neurol Psychiatr; 2008 Oct; 76(10):594-9. PubMed ID: 18833504 [Abstract] [Full Text] [Related]
19. Quantitative description of loss of clinical benefit following withdrawal of levodopa-carbidopa and bromocriptine in early Parkinson's disease. Hauser RA, Holford NH. Mov Disord; 2002 Sep; 17(5):961-8. PubMed ID: 12360545 [Abstract] [Full Text] [Related]